Author:
Peters H. D.,Staszewski S.
Publisher
Springer Berlin Heidelberg
Reference38 articles.
1. Boehm MF, Zhang L, Zhi L, et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 1995; 38: 3146–3155
2. Chambon P. The molecular and genetic dissection of the retinoid signalling pathway. Rec Prog Horm Res 1995; 50: 317–332
3. Drug Information for the Health Care Professional, USP’DI (2002, 22nd Edition, Micromedex-Thompson Healthcare): pp 639–643
4. Duvic M, Hymes K, Heald P, et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase 11–111 trial results. J Clin Oncol 2001 ; 19: 2456–2471
5. Miller VA, Benedetti FM, Rigas JR, et al. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997; 15:790–795